Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,060 | 5,951 | -1,496 | 4,656 | 4,741 |
| Depreciation Amortization | 2,253 | 1,899 | 1,911 | 1,992 | 919 |
| Income taxes - deferred | N/A | N/A | N/A | 542 | 57 |
| Accounts receivable | 2,178 | 192 | -2,499 | 1,705 | -2,347 |
| Accounts payable and accrued liabilities | 183 | 1,585 | -925 | 91 | 315 |
| Other Working Capital | 465 | 2,135 | -3,056 | -489 | 1,681 |
| Other Operating Activity | -892 | -576 | 5,174 | -1,568 | 1,707 |
| Operating Cash Flow | $2,127 | $11,186 | $-891 | $6,929 | $7,073 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 15,353 |
| PPE Investments | -2,840 | -3,564 | -1,708 | -2,048 | -522 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -14,516 |
| Investing Cash Flow | $-2,840 | $-3,564 | $-1,708 | $-2,048 | $315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,455 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,402 | -226 | -238 | -245 | -72 |
| Common Stock Issued | N/A | N/A | 82 | 33 | 11 |
| Common Stock Repurchased | N/A | N/A | -22 | -8,509 | 0 |
| Dividend Paid | -14 | -28 | -28 | -28 | -28 |
| Financing Cash Flow | $1,039 | $-254 | $-206 | $-8,749 | $-89 |
| Exchange Rate Effect | 126 | -275 | -56 | -85 | 212 |
| Beginning Cash Position | 20,994 | 13,901 | 16,762 | 20,715 | 13,204 |
| End Cash Position | 21,446 | 20,994 | 13,901 | 16,762 | 20,715 |
| Net Cash Flow | $452 | $7,093 | $-2,861 | $-3,953 | $7,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,127 | 11,186 | -891 | 6,929 | 7,073 |
| Capital Expenditure | -2,840 | -3,564 | -1,708 | -2,048 | -522 |
| Free Cash Flow | -713 | 7,622 | -2,599 | 4,881 | 6,551 |